TrialRheumatology (Oxford, England)2023

Sustained glucocorticoid tapering in the phase 3 trials of anifrolumab: a post hoc analysis of the TULIP-1 and TULIP-2 trials.

Ian N Bruce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.